Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-07

Clinical Trial Update: Naltrexone Treatment for Alcoholic Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on naltrexone for alcoholic women. The study, addressing alcoholism and eating disorders, is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Alcoholism, Eating Disorder | Phase 4 | Status: COMPLETED